This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed Review

Erosive arthritis

Georg Schett

Arthritis Research & Therapy 2007, 9(Suppl 1):S2 doi:10.1186/ar2166

Accesses  

  • Last 30 days: 165 accesses
  • Last 365 days: 2194 accesses
  • All time: 11024 accesses

Cited by

BioMed Central: 2 citations

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations